Follow @EmmKay_RA
Stocks in news
Results on Friday:
Tomorrow is the result day of a good number of following company which would be in ( Stock in Action ) because of its business performance and expectation. keep track on the movement.
Reliance Industries, ICICI Bank, Bank of Baroda, Alembic Pharma, Equitas Holding, HCL Technologies, Indian Overseas Bank, Jubilant Life science, M&M Financial Services, Shopper Stop, Westlife Development, Apcotex Industries, Coromandel International, DIC India, Excel Crop, Gallantt Ispat, Genus Power, Heritage Foods, IL&FS Transportation, IRB InvIT, Jayaswal Neco, JSW Energy, KIC Metaliks, Kirloskar Brothers, Mafatlal Finance, Nagarjuna Fertilizer, Phillips Carbon, Prestige Estate, RPG Life, Schneider Electric, TRF, Welspun India.
The breadth of the market favoured advances, with 942 stocks advancing, 764 declining and 352 remaining unchanged. On BSE, 1348 stocks advanced, 1208 declined and 122 remained unchanged.
According to a report on CNBC-TV18, the company has received a voluntary action initiated (VAI) status for its Halol plant from US FDA.
Under this agreement, Lilly’s BASAGLAR that is manufactured by Lilly will be marketed and distributed in India by Cipla.
57 stocks hit a new 52-week low. These include Kwality, Alembic Pharma, Manpasand Beverages, Kwality, VA Tech Wabag and Videocon Industries among others.
The company approved the proposal to invest an amount up to Rs 400 crore in its wholly-owned subsidiary company HT Music and Entertainment Company.
The company announced the launch as well as export of its full electric feeder bus eBuzz KG, the 1st bus in this category to be manufactured in India.
There were pending buy orders of 75 shares, with no sellers available.
The breadth of the market favoured advances, with 1388 stocks advancing, 306 declining and 360 remaining unchanged. On BSE, 1861 stocks advanced, 617 declined and 106 remained unchanged.
Banking stocks resumed their uptrend after trimming some gains immediately after the RBI policy outcome was announced.
The Bank Nifty and Nifty PSU bank had both trimmed gains on the back of hiking of repo as well as repo rates. The resumption of trend is possible after reading into the fine-print of the central bank’s statement.
The company#39;s share in the joint venture is 40 percent (USD 44 million / Rs 295 crore).
Bajaj Finance has acquired additional 3.64 percent stake in the company stake in the company via encumbrance.
Sectors like banking, real estate and auto, among others, will be impacted the most from the rate hike as the cost of the products will be directly influenced due to increase in interest rate.
The company#39;s formulation manufacturing facility at Ghaziabad has received an EIR from USFDA.
Positional traders are advised to buy into this counter for a target of Rs 970 and a stop loss below Rs 900.
The stock is witnessing high volume along with the support placed at 20 and 50-days SMA.
Methylergonovine Maleate tablet is the generic equivalent of Novartis Pharmaceuticals Corporation#39;s Methergine.
The fund house has purchased 72,67,679 equity shares of the company at Rs 34.08 apiece through bulk deals on the National Stock Exchange.